孤独症不同临床(适应)结局的横断面与纵向神经解剖学特征
该纵向随访研究纳入333名6-30岁个体(161名孤独症患者和172名神经典型者),间隔约12-24个月进行两次评估,依据VABS-II将孤独症患者分为适应行为「增加组」「不变组」和「减少组」,比较各组与神经典型者的脑表面积和皮层厚度差异,并探索其基因组关联,发现不同临床结局具有不同的横断面和纵向神经解剖学特征,且这些特征富集于既往与孤独症相关的基因。
要点
- 孤独症患者适应行为轨迹可分为增加组、不变组和减少组,各组具有不同的基线及纵向神经解剖学特征。
- 不同临床结局亚组的脑表面积和皮层厚度差异富集于既往与孤独症相关的基因及兴奋-抑制系统等通路。
- 若经验证,这些发现可能推动针对预后较差相关机制的干预开发。
核心结论
- 与孤独症核心症状相关的不同临床结局(即临床特征的个体内变化)与不典型的横断面及纵向发育神经生物学特征相关。
研究设计与样本
- 纵向随访研究,纳入333名6-30岁个体(161名孤独症患者和172名神经典型者),两次评估间隔约12-24个月,采集VABS-II行为数据和结构磁共振成像神经解剖数据。
主要发现
- 孤独症临床亚组在基线、神经解剖发育(个体内变化)和随访时的脑表面积与皮层厚度上具有不同特征。
- 这些神经解剖特征富集于既往与孤独症相关的基因以及兴奋-抑制系统等孤独症相关神经生物学通路的基因。
关键数值与推荐
- 依据VABS-II评分将孤独症参与者分为临床有意义的适应行为「增加组」「不变组」和「减少组」。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Individuals with autism spectrum disorder (henceforth referred to as autism) display significant variation in clinical outcome. For instance, across age, some individuals' adaptive skills naturally improve or remain stable, while others' decrease. To pave the way for 'precision-medicine' approaches, it is crucial to identify the cross-sectional and, given the developmental nature of autism, longitudinal neurobiological (including neuroanatomical and linked genetic) correlates of this variation. We conducted a longitudinal follow-up study of 333 individuals (161 autistic and 172 neurotypical individuals, aged 6-30 years), with two assessment time points separated by ~12-24 months. We collected behavioural (Vineland Adaptive Behaviour Scale-II, VABS-II) and neuroanatomical (structural magnetic resonance imaging) data. Autistic participants were grouped into clinically meaningful "Increasers", "No-changers", and "Decreasers" in adaptive behaviour (based on VABS-II scores). We compared each clinical subgroup's neuroanatomy (surface area and cortical thickness at T1, ∆T (intra-individual change) and T2) to that of the neurotypicals. Next, we explored the neuroanatomical differences' potential genomic associates using the Allen Human Brain Atlas. Clinical subgroups had distinct neuroanatomical profiles in surface area and cortical thickness at baseline, neuroanatomical development, and follow-up. These profiles were enriched for genes previously associated with autism and for genes previously linked to neurobiological pathways implicated in autism (e.g. excitation-inhibition systems). Our findings suggest that distinct clinical outcomes (i.e. intra-individual change in clinical profiles) linked to autism core symptoms are associated with atypical cross-sectional and longitudinal, i.e. developmental, neurobiological profiles. If validated, our findings may advance the development of interventions, e.g. targeting mechanisms linked to relatively poorer outcomes.
引用
- Pretzsch CM, Floris DL, Schäfer T, et al. Cross-sectional and longitudinal neuroanatomical profiles of distinct clinical (adaptive) outcomes in autism. Mol Psychiatry. 2023. PMID: 36991132. doi:10.1038/s41380-023-02016-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。